PharmaBiome Analysis: $2M Raised
What is PharmaBiome?
Functional microbiome therapies based on research
Location
Schlieren, Switzerland
Employees
11-50
Founded
2015
Product Features & Capabilities
- Function-based microbiome therapies
- Proprietary technologies for bacterial consortia design
- Research collaborations in microbiome R&D
Use Cases
Develop tailored bacterial consortia for inflammatory bowel disease; Engineer microbiome therapies for metabolic disorders; Collaborate with partners for microbiome research; Design function-based therapies for dysbiosis; Produce scalable microbiome solutions for clinical applications
Other Considerations
Collaboration with Ferring for microbiome R&D; Recognized for research published in Gut Microbes; Backed by ETH Zurich expertise in microbiology and biotechnology
See something that needs updating? Suggest edits to this profile.